Loss of FancC function results in decreased hematopoietic stem cell repopulating ability

Laura S. Haneline, Troy A. Gobbett, Rema Ramani, Madeleine Carreau, Manuel Buchwald, Mervin C. Yoder, D. Wade Clapp

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

Fanconi anemia (FA) is a complex genetic disorder characterized by progressive bone marrow (BM) aplasia, chromosomal instability, and acquisition of malignancies, particularly myeloid leukemia. We used a murine model containing a disruption of the murine homologue of FANCC (FancC) to evaluate short- and long-term multilineage repopulating ability of FancC -/- cells in vivo. Competitive repopulation assays were conducted where 'test' FancC -/- or FancC +/+ BM cells (expressing CD45.2) were cotransplanted with congenic competitor cells (expressing CD45.1) into irradiated mice. In two independent experiments, we determined that FancC -/- BM cells have a profound decrease in short-term, as well as long-term, multilineage repopulating ability. To determine quantitatively the relative production of progeny cells by each test cell population, we calculated test cell contribution to chimerism as compared with 1 x 105 competitor cells. We determined that FancC -/- cells have a 7-fold to 12-fold decrease in repopulating ability compared with FancC +/+ cells. These data indicate that loss of FancC function results in reduced in vivo repopulating ability of pluripotential hematopoietic stem cells, which may play a role in the development of the BM failure in FA patients. This model system provides a powerful tool for evaluation of experimental therapeutics on hematopoietic stem cell function.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalBlood
Volume94
Issue number1
StatePublished - Jul 1 1999

Fingerprint

Hematopoietic Stem Cells
Stem cells
Bone
Fanconi Anemia
Bone Marrow Cells
Assays
Bone Marrow
Cells
Chromosomal Instability
Chimerism
Inborn Genetic Diseases
Myeloid Leukemia
Experiments
Population
Neoplasms

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. / Haneline, Laura S.; Gobbett, Troy A.; Ramani, Rema; Carreau, Madeleine; Buchwald, Manuel; Yoder, Mervin C.; Clapp, D. Wade.

In: Blood, Vol. 94, No. 1, 01.07.1999, p. 1-8.

Research output: Contribution to journalArticle

Haneline, LS, Gobbett, TA, Ramani, R, Carreau, M, Buchwald, M, Yoder, MC & Clapp, DW 1999, 'Loss of FancC function results in decreased hematopoietic stem cell repopulating ability', Blood, vol. 94, no. 1, pp. 1-8.
Haneline LS, Gobbett TA, Ramani R, Carreau M, Buchwald M, Yoder MC et al. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood. 1999 Jul 1;94(1):1-8.
Haneline, Laura S. ; Gobbett, Troy A. ; Ramani, Rema ; Carreau, Madeleine ; Buchwald, Manuel ; Yoder, Mervin C. ; Clapp, D. Wade. / Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. In: Blood. 1999 ; Vol. 94, No. 1. pp. 1-8.
@article{d18ca7e9c52e4e4897a09ce0aeb1f506,
title = "Loss of FancC function results in decreased hematopoietic stem cell repopulating ability",
abstract = "Fanconi anemia (FA) is a complex genetic disorder characterized by progressive bone marrow (BM) aplasia, chromosomal instability, and acquisition of malignancies, particularly myeloid leukemia. We used a murine model containing a disruption of the murine homologue of FANCC (FancC) to evaluate short- and long-term multilineage repopulating ability of FancC -/- cells in vivo. Competitive repopulation assays were conducted where 'test' FancC -/- or FancC +/+ BM cells (expressing CD45.2) were cotransplanted with congenic competitor cells (expressing CD45.1) into irradiated mice. In two independent experiments, we determined that FancC -/- BM cells have a profound decrease in short-term, as well as long-term, multilineage repopulating ability. To determine quantitatively the relative production of progeny cells by each test cell population, we calculated test cell contribution to chimerism as compared with 1 x 105 competitor cells. We determined that FancC -/- cells have a 7-fold to 12-fold decrease in repopulating ability compared with FancC +/+ cells. These data indicate that loss of FancC function results in reduced in vivo repopulating ability of pluripotential hematopoietic stem cells, which may play a role in the development of the BM failure in FA patients. This model system provides a powerful tool for evaluation of experimental therapeutics on hematopoietic stem cell function.",
author = "Haneline, {Laura S.} and Gobbett, {Troy A.} and Rema Ramani and Madeleine Carreau and Manuel Buchwald and Yoder, {Mervin C.} and Clapp, {D. Wade}",
year = "1999",
month = "7",
day = "1",
language = "English (US)",
volume = "94",
pages = "1--8",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Loss of FancC function results in decreased hematopoietic stem cell repopulating ability

AU - Haneline, Laura S.

AU - Gobbett, Troy A.

AU - Ramani, Rema

AU - Carreau, Madeleine

AU - Buchwald, Manuel

AU - Yoder, Mervin C.

AU - Clapp, D. Wade

PY - 1999/7/1

Y1 - 1999/7/1

N2 - Fanconi anemia (FA) is a complex genetic disorder characterized by progressive bone marrow (BM) aplasia, chromosomal instability, and acquisition of malignancies, particularly myeloid leukemia. We used a murine model containing a disruption of the murine homologue of FANCC (FancC) to evaluate short- and long-term multilineage repopulating ability of FancC -/- cells in vivo. Competitive repopulation assays were conducted where 'test' FancC -/- or FancC +/+ BM cells (expressing CD45.2) were cotransplanted with congenic competitor cells (expressing CD45.1) into irradiated mice. In two independent experiments, we determined that FancC -/- BM cells have a profound decrease in short-term, as well as long-term, multilineage repopulating ability. To determine quantitatively the relative production of progeny cells by each test cell population, we calculated test cell contribution to chimerism as compared with 1 x 105 competitor cells. We determined that FancC -/- cells have a 7-fold to 12-fold decrease in repopulating ability compared with FancC +/+ cells. These data indicate that loss of FancC function results in reduced in vivo repopulating ability of pluripotential hematopoietic stem cells, which may play a role in the development of the BM failure in FA patients. This model system provides a powerful tool for evaluation of experimental therapeutics on hematopoietic stem cell function.

AB - Fanconi anemia (FA) is a complex genetic disorder characterized by progressive bone marrow (BM) aplasia, chromosomal instability, and acquisition of malignancies, particularly myeloid leukemia. We used a murine model containing a disruption of the murine homologue of FANCC (FancC) to evaluate short- and long-term multilineage repopulating ability of FancC -/- cells in vivo. Competitive repopulation assays were conducted where 'test' FancC -/- or FancC +/+ BM cells (expressing CD45.2) were cotransplanted with congenic competitor cells (expressing CD45.1) into irradiated mice. In two independent experiments, we determined that FancC -/- BM cells have a profound decrease in short-term, as well as long-term, multilineage repopulating ability. To determine quantitatively the relative production of progeny cells by each test cell population, we calculated test cell contribution to chimerism as compared with 1 x 105 competitor cells. We determined that FancC -/- cells have a 7-fold to 12-fold decrease in repopulating ability compared with FancC +/+ cells. These data indicate that loss of FancC function results in reduced in vivo repopulating ability of pluripotential hematopoietic stem cells, which may play a role in the development of the BM failure in FA patients. This model system provides a powerful tool for evaluation of experimental therapeutics on hematopoietic stem cell function.

UR - http://www.scopus.com/inward/record.url?scp=0033168321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033168321&partnerID=8YFLogxK

M3 - Article

C2 - 10381491

AN - SCOPUS:0033168321

VL - 94

SP - 1

EP - 8

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -